Evidence map›Paper›PMID 35478155›Full record

ArticleIn vivo (Athens, Greece)

Implementation of

Ryo Toya, Takahiro Watakabe, Yudai Kai, Tomohiko Matsuyama, Yoshiyuki Fukugawa, Tadashi Matsumoto, Shinya Shiraishi, Yoshinobu Shimohigashi, Sho Saeki, Takuro Sakagami and 2 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Radiological physics and technology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ryo ToyaDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ryo108@kumamoto-u.ac.jp.
Takahiro WatakabeDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yudai KaiDepartment of Radiological Technology, Kumamoto University Hospital, Kumamoto, Japan.
Tomohiko MatsuyamaDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshiyuki FukugawaDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Tadashi MatsumotoDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Shinya ShiraishiDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Yoshinobu ShimohigashiDepartment of Radiological Technology, Kumamoto University Hospital, Kumamoto, Japan.
Sho Saekidepartment of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Takuro Sakagamidepartment of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Toshinori HiraiDepartment of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Natsuo OyaDepartment of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kumamoto University · JPKumamoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThis is a report of the first clinical implementation of CASE REPORT: A 48-year-old man developed chemo-refractory diffuse liver metastases from thymic carcinoma characterized by abdominal pain and distension. Palliative RT was performed with a total dose of 20 Gy in five fractions using double arc volumetric modulated arc therapy to reduce the dose to functional liver defined by

conclusionThe

Indexed as

Liver NeoplasmsRadiopharmaceuticalsHumansMaleMiddle AgedTechnetium Tc 99m Aggregated AlbuminTechnetium Tc 99m PentetateTomography, Emission-Computed, Single-PhotonRadiopharmaceuticalsTechnetium Tc 99m Aggregated Albumintechnetium Tc 99m DTPA-galactosyl-human serum albuminTechnetium Tc 99m Pentetatefunctional imagingMetastatic liver tumorpalliative treatmentradiotherapysingle-photon emission computed tomographyvolumetric modulated arc radiotherapy

Identifiers

PMID35478155
PMCPMC9087087
OpenAlexW4225098771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.